Cardiovascular surgery in patients with HIV: Epidemiology, current indications, and long-term outcome;Cirugía cardiovascular en pacientes con VIH: Epidemiología, indicaciones actuales y resultados a largo plazo

Revista Espanola de Cardiologia

Volumn 61, Issue 5, 2008, Pages 480-486

  Castillo, Javier G ^a,b   Adams, David H ^a   Rahmanian, Parwis B ^a   Filsoufi, Farzan ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Epidemiology; Lymphocytes; Surgery; Survival

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGED; AORTA DISEASE; ARTICLE; CARDIOVASCULAR SURGERY; CARDIOVASCULAR SYMPTOM; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOCARDITIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MALE; MORTALITY; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; REOPERATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; STROKE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 46449103287     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13119991     Document Type: Article

References (24)

1. Increases in HIV diagnoses - 29 States, 1999-2002. MMWR Morb Mort Wkly Rep. 2003;52:1145-8.
2. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60.
3. Palella FJ Jr, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138:620-6.
4. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA. 1993;269:729-30.
5. Aris A, Pomar JL, Saura E. Cardiopulmonary bypass in HIV-positive patients. Ann Thorac Surg. 1993;55:1104-7.
6. Mestres CA, Chuquiure JE, Claramonte X, Munoz J, Benito N, Castro MA, et al. Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1). Eur J Cardiothorac Surg. 2003;23:1007-16.
7. Trachiotis GD, Alexander EP, Benator D, Gharagozloo F. Cardiac surgery in patients infected with the human immunodeficiency virus. Ann Thorac Surg. 2003;76:1114-8.
8. Blyth DF, Buckels NJ, Sewsunker RR, Khan S, Mathivha TM. An experience with cardiopulmonary bypass in HIV-infected patients. Cardiovasc J S Afr. 2006;17:178-85.
9. Jiménez-Expósito MJ, Mestres CA, Claramonte X, Cartana R, Josa M, Pomar JL, et al. Morbimortalidad en pacientes con infección por el virus de la inmunodeficiencia humana que reciben cirugía de revascularización miocárdica: estudio de casos y controles. Rev Esp Cardiol. 2006;59:276-9.
10. Buehler JW, Berkelman RL, Curran JW. Reporting of AIDS: tracking HIV morbidity and mortality. JAMA. 1989;262:2896-7.
11. Shah SS, Roxburgh JC, Loveday C, Goldstraw P, Yacoub MH. HIV-1 infection and cardiothoracic surgery: the difference in attitudes between consultants and junior surgeons in the United Kingdom. Eur J Cardiothorac Surg. 1992;6:279-83.
12. Sousa Uva M, Jebara VA, Fabiani JN, Castel SM, Acar C, Grare P, et al. Cardiac surgery in patients with human immunodeficiency virus infection: indications and results. J Cardiac Surg. 1992;7:240-4.
13. Carrel T, Schaffner A, Vogt P, Laske A, Niederhauser U, Schneider J, et al. Endocarditis in intravenous drug addicts and HIV infected patients: possibilities and limitations of surgical treatment. J Heart Valve Dis. 1993;2:140-7.
14. Frater RW, Comacho M, Frymus M, Soeiro R, Zingman BS. Cardiac surgery in the patient with human immunodeficiency virus. Adv Cardiol. 2003;40:219-25.
15. Chong T, Alejo DE, Greene PS, Redmond JM, Sussman MS, Baumgartner WA, et al. Cardiac valve replacement in human immunodeficiency virus-infected patients. Ann Thorac Surg. 2003;76:478-80.
16. Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328.
17. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease. J Clin Endocrinol Metab. 2007;92:2506-12.
18. Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32:130-9.
19. Martinez E, Mocroft A, Garcia-Viejo MA, Perez-Cuevas JB, Blanco JL, Mallolas J, et al. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Lancet. 2001;357:592-8.
20. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003;289:2978-82.
21. Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, et al. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS (London). 2005;19:1375-83.
22. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352:48-62.
23. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350:1387-97.
24. Sudano I, Spieker LE, Noll G, Corti R, Weber R, Luscher TF. Cardiovascular disease in HIV infection. Am Heart J. 2006;151: 1147-55.